Itaconic acid
Names | |
---|---|
Preferred IUPAC name
Methylidenebutanedioic acid | |
Other names | |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.002.364 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C5H6O4 | |
Molar mass | 130.099 g·mol−1 |
Appearance | White solid |
Density | 1.63 g/cm3[1] |
Melting point | 162 to 164 °C (324 to 327 °F; 435 to 437 K) (decomposes)[1] |
1 g/12 mL[1] | |
Solubility in ethanol | 1 g/5 mL[1] |
-57.57·10−6 cm3/mol | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Itaconic acid (also termed methylidenesuccinic acid and 2-methylidenebutanedioic acid
Animal cells make itaconate by an
In 1836, Samuel Baup discovered a previously unknown
The following section, titled "Biology of Itaconate," details
Biology of Itaconate
Cells making itaconate
While many cell types can be manipulated to produce itaconate, the major
Itaconate-forming metabolic pathway
Itaconate is a by-product of the tricarboxylic acid cycle. This cycle consists of eight successive enzyme-catalyzed
- citrate
This cyclical metabolic pathway serves the vital function of releasing the energy stored in nutrients to its cell of origin and in multicellular organisms' other cells throughout the body.[6][20] Recent studies have found that some of the metabolites in the tricarboxylic acid cycle stimulate physiological and pathological responses, i.e., they are bioactive metabolites. For example, cells undergoing stress suppress the tricarboxylic acid cycle's operation. This causes succinate to accumulate.[20][21][22] The accumulating succinate stimulates a wide range of mostly pathological (e.g., cardiac ventricular hypertrophy)[22]) and pro-inflammatory[23] (e.g., Crohn's disease)[24] disorders. High levels of succinate do have some beneficial actions such as promoting the neovascularization of tissues suffering vascular occlusions.[25] Succinate produces these effects by activating its G protein-coupled receptor, i.e., SUCNR1, in cells bearing this receptor but also by stimulating cells not bearing SUCNR1 as well as SUCNR1-bearing cells by receptor-independent mechanisms.[21][26] Itaconate is also a bioactive metabolite. When operation of the tricarboxylic acid cycle is suppressed, one of its metabolites, cis-aconitate, accumulates. Aconitate decarboxylase (also termed ACOD1, cis-aconitate decarboxylase, immune-responsive gene 1, immune response gene 1, immunoregulatory gene 1, and IRG1[27][28][29][30]) metabolizes cis-aconitate to itaconate and carbon dioxide (CO2) in the following decarboxylation reaction:[14][24]
- cis-aconitate → itaconate + CO2
This itaconate is transported across the mitochondrial membrane into the cell's cytosol by the mitochondrial dicarboxylate carrier protein, mitochondrial 2-oxoglutarate/malate carrier protein, and citrate–malate shuttle.[31] The cytosolic itaconate may then move form the cytosol through the patents cells surface membrane to the extracellular space (this trans-membrane movement may involve a specific transport protein such as the major facilitator superfamily transport protein (i.e., MfsA) in fungi.[32]) This itaconate has mostly anti-inflammatory actions.[19][23] It acts on its parent cell, other cells, and certain microorganism[6] by stimulating or inhibiting the activity of various response-regulating pathways in its parent cell, other cells, and bacteria. Itaconate's actions on its parent and other cells were considered as entirely independent of any receptor. Very recently, however, itaconate has been reported to stimulate certain mammalian cells by activating the OXGR1 receptor.[33][34]
OXGR1 receptor
OXGR1 (also known as GPR99) is a G protein-coupled receptor that was identified in 2004 as a receptor for the tricarboxylic cycle intermediate, α-ketoglutarate.[33] In 2013, it was found to also be a receptor for leukotriene E4 and to lesser extents leukotriene C4 and D4.[35][36] AZeng et al.[33] reported in 2023 that: a) among a set of cultured human embryonic kidney HEK 293 cells made to express any one of 351 different human G protein-coupled receptors, only cells expressing OXGR1 responded to itaconate by raising their cytosolic Ca2+ levels; b) HEK 293 cells expressing any of the other 350 receptors did not consistently alter their cytosolic Ca2+ levels in response to itaconate; c) respiratory epithelium cells isolated from control mice (i.e., these cells naturally express OXGR1) but not from Oxgr1 gene knockout mice (i.e., these cells lacked OXRG1) responded to itaconic acid by raising their cytosolic Ca2+ levels and stimulating their mucociliary clearance (equivalent to stimulating the secretion of mucus); d) application of itaconate in the noses of control mice but not Oxgr1 gene knockout mice stimulated nasal secretion of mucus; e) Oxgr1 gene knockout mice and Irg1 gene knockout mice (mice lacking the itaconate-producing protein, IRG1) that were intranasally infected with Pseudomonas aeruginosa had increased numbers of these bacteria in their lung tissue and bronchoalveolar lavage fluid (i.e., airway washing) than control mice that respectively expressed OXGR1 and IRG1 and f) α-ketoglutarate and itaconate, which have similar structures, activated OXGR1-exressing HEK293 cells at similar concentrations, i.e., between 200–300 μM/liter.[33][34] These findings ate the first to indicate that itaconate stimulates human HEK 293 and mouse respiratory epithelial cells by activating their OXGR1 receptors. Since OXGP1 is expressed in a wide range of tissues and mediates the allergic and inflammatory responses to the cited leukotrienes,[34] it may be involved in the inflammatory responses detailed in the following "Actions of itaconate and its analogs" section. That is, itaconate, like succinate (see previous paragraph), may stimulate cells by receptor-dependent and receptor independent mechanisms. Future studies need to determine the extent to which OXGR1 contributes to the various actions of itaconate and itaconate-like compounds (see next section) as well as the potencies of each of these agents in activating OXGR1.[23][33][34]
Itaconate and itaconate-like compounds
4-Octyl itaconate, dimethyl itaconate,[9] and 4-ethyl itaconate[6] have been used to mimic the biological effects of itaconate. These functional analogs of itaconate are often used in place of itaconate because of their presumed greater ability to pass through the surface membranes of, and thereby enter, cells. In should be noted that many studies have examined the actions of itaconate analogs rather than itaconate itself and that itaconate and these three analogs have on occasion shown significantly different biological activities.[7][14][19][37][38]
The anionic forms of
Dietary sources of itaconate and its isomers
Itaconic acid and its two isomers, mesaconic and citraconic acids, were found in rye and wheat breads with appreciably higher concentrations of itaconic and citraconic acids in their crusts (i.e., outer bread layer) than crumbs (i.e., soft inner part of the bread). Based on the average consumption of bread and bread-related baked goods in Germany, the daily intake of itaconate plus its two isomers was estimated to be from 7 to 20 micrograms. Rats have been shown to absorb the itaconic acid that was added to their diet. Further studies are needed to determine the levels of these compounds in other foods, the extent to which itaconic acid and itaconic acid-like compounds are absorbed by humans, and the usefulness of treating itaconate-suppressing disorders with oral itaconic acid or the acidic forms of the itaconic acid-like compounds.[39]
Actions of itaconate and its analogs
Itaconate and its analogs can operate concurrently through multiple pathways to induce their effects.[42][43][44] Relevant to this, future studies must determine the role of the newly defined receptor for itaconate, OXGR1, in contributing to the mediation of the following actions of itaconate and itaconate-like compounds.[33]
Inhibit succinate dehydrogenase
Succinate dehydrogenase (i.e., SDH) is an enzyme complex of six proteins in the mitochondrial tricarboxylic acid cycle that metabolizes succinate to fumarate.[27] (Although bacteria generally lack mitochondria,[45] their surface membranes have a similar SDH system.[46]) Itaconate inhibits SDH's activity thereby blocking succinate's oxidation to fumarate and causing succinate levels to increase. Itaconate has been reported to increase succinate levels in a wide variety of cells including cultured mouse RAW264.7 macrophages, macrophages differentiated from human monocytes,[37] Huh7 human liver carcinoma cells, human MCF-7 breast cancer cells, human A549 lung adenocarcinoma cells, and the brain neurons and astrocytes generated from rat embryo brain tissue.[47] This succinate stimulates various responses in its parent and other cells as detailed elsewhere (see SUCNR1 and succinic acid).[20][21][48]
Inactivate KEAP1
In a model of intracellular inflammation, LPS stimulated mouse bone marrow-derived macrophages to increase their levels of IL-1β, tumor necrosis factor, hypoxia-inducible factor 1-alpha, and reactive oxygen species. 4-Octyl itaconate suppressed all of these LPS-induced responses. It also reduced the production of IL-1β and tumor necrosis factor in LPS-stimulated human peripheral blood monocytes. And, in a model of LPS-induced septic shock, mice injected intraperitoneally with LPS plus 4-octyl itaconate had fewer physical symptoms of shock, lower serum levels of the pro-inflammatory cytokines, IL-1β and tumor necrosis factor, unchanged levels of the anti-inflammatory cytokine interleukin 10, and longer survival times compared to mice treated with LPS but not 4-octyl itaconate. Thus, the inhibitory effects of 4-octyl itaconate, dimethyl itaconate, and itaconate on cells appear due to their inactivation of KEAP1 and resulting movement of cytosolic Nrf2 into the cell nucleus where it inhibits its target genes from producing reactive oxygen species and the cited inflammation-promoting proteins. This mechanism may also underlie 4-octyl itaconate's ability to reduce the severity of LPS-induced shock in mice.[31]
Inhibit NLRP3
The
In one study,
Increase ATF3 levels
ATF3 (i.e., cyclic AMP-dependent transcription factor ATF-3) is a transcription factor that inhibits the NFKBIZ gene's expression of NF-kappa-B inhibitor zeta (i.e., IκBζ), a protein located in the cell nucleus that promotes the production of certain pro-inflammatory cytokines such as IL-6,[14][43] interferon gamma, and granulocyte-macrophage colony-stimulating factor.[43][44] Itaconate and dimethyl itaconate stimulate the production of ATF3 thereby suppressing the cellular levels of IκBζ and IL-6 as well as IL-6-promoted inflammatory responses.[7][14][56]
Studies have shown that: a) Atf3 gene knockout embryonic mouse
Inhibit Tet methylcytosine dioxygenase 2
Studies have shown that: a) itaconate blocked α-ketoglutarate from binding to and thereby activating the isolated TET2 protein in a cell-free system; 2) TET2 gene knockout bone marrow-derived macrophages (i.e., BMDMs) had far lower levels of hydroxymethylcytosine in their DNA than control macrophages; c) itaconate and 4-octyl itaconate lowered the amount of hydroxymethylcytosine in the DNA of control but not in TET2 gene knockout BMDMs; d) LPS stimulation of mouse macrophage RAW264.7 cells (these cells express TET2) caused increases in their levels of the
Inhibit interleukin 17A
Interleukin 17 (i.e., IL-17) refers to any one of 6 different but closely related subtypes, IL-17A to IL17F. IL-17A is a pro-inflammatory cytokine that is commonly elevated in cells undergoing inflammatory responses.[59] (Some studies used the term IL-17 when referring to IL-17A or when the subtype of IL-17 measured was undefined.) Excessive IL-17A production appears to contribute to the development of various autoimmune diseases[64] by stabilizing the messenger RNA for IκBζ and thereby increasing cellular levels of IκBζ protein and IL-6.[42][59]
A study focusing on models of the skin autoimmune disease
Antibacterial actions
Itaconate can act directly on certain types of bacteria to limit their growth and disease-causing abilities. The enzyme
Studies examining the effects of itaconate and itaconate-like compounds on phagocytosed bacterial have reported that: a) mouse bone marrow-derived macrophages exposed to live or heat-killed Staphylococcus aureus rapidly (i.e., within 1 hour) developed increases in their levels of IRG1 and IRG1's metabolite, itaconate; b ) human
Antiviral actions
Itaconate suppresses the growth of certain disease-causing viruses.
4-Octyl itaconate also suppresses the proliferation of
Anti-cancer actions
Individuals with
Varying actions of itaconate and its analogs
One study
Commercial production and uses of itaconic acid
Itaconic acid is a non-toxic
Itaconic acid's chemical structure consists of one unsaturated
Recently, the demand for itaconic acid has grown to such an extent that it is projected to reach a market value of 177 million dollars per year in United States of American currency by 2028. Consequently, alternate methods for making products with properties similar or identical to those made from itaconic acid by using less costly substitutes for itaconic acid and/or methods that are more productive, less expensive, and/or more environmental-friendly than those used for itaconic acid are being evaluated.[15] Betulin, for example, is an abundant, naturally occurring diol triterpene that is readily isolated from the bark of birch trees. Betulin forms polymers that have some of the biochemical properties found in itaconate polymers. Consequently, botulin is being studied to determine if it can be used in place of itaconic acid to form products with properties similar to those made from itaconic acid but doing so in economically and/or environmentally more favorable ways.[15]
References
- ^ a b c d e Merck Index, 11th Edition, 5130
- PMID 26971832.
- ^ PMID 29536145.
- ^ PMID 37852066.
- PMID 37713987.
- ^ PMID 36459716.
- ^ PMID 38042791.
- ^ PMID 23610393.
- ^ PMID 30096309.
- PMID 35479465.
- PMID 21919507.
- PMID 3651434.
- PMID 32601305.
- ^ PMID 35040439.
- ^ PMID 37771764.
- ^ PMID 36376563.
- PMID 36724077.
- ^ PMID 37707952.
- ^ PMID 38487538.
- ^ PMID 36581208.
- ^ S2CID 236097682.
- ^ PMID 25539979.
- ^ PMID 37940417.
- ^ PMID 37446354.
- PMID 33918298.
- S2CID 227522279.
- ^ PMID 31039394.
- ^ PMID 34095879.
- ^ PMID 35025971.
- PMID 35782110.
- ^ PMID 29590092.
- PMID 36122598.
- ^ PMID 36919698.
- ^ PMID 38448252.
- PMID 23504326.
- PMID 31135881.
- ^ PMID 35655024.
- ^ PMID 32694786.
- ^ PMID 35883873.
- ^ PMID 36446152.
- PMID 35024614.
- ^ PMID 33968407.
- ^ PMID 37377955.
- ^ PMID 27579619.
- PMID 28664324.
- PMID 22474332.
- PMID 33670656.
- ^ PMID 27374498.
- ^ PMID 36750315.
- ^ PMID 33391283.
- PMID 32853548.
- PMID 31032474.
- PMID 35513901.
- PMID 31508424.
- ^ PMID 32791101.
- ^ PMID 29670287.
- PMID 16688168.
- PMID 37209857.
- ^ PMID 36245291.
- ^ PMID 33085059.
- PMID 26287468.
- PMID 28826859.
- ^ PMID 35256775.
- PMID 31718798.
- PMID 32070069.
- PMID 33692806.
- ^ PMID 26565676.
- PMID 32899140.
- PMID 34079536.
- PMID 36327660.
- PMID 26829557.
- PMID 31672889.
- PMID 32428444.
- PMID 38157877.
- ^ PMID 33009401.
- PMID 30635240.
- PMID 35643170.
- PMID 32840638.
- ^ PMID 37417104.
- ^ PMID 35654783.
- PMID 10507539.
- ^ PMID 34293399.
- PMID 32272379.
- PMID 37596643.
- .
- PMID 23727192.
- .
- PMID 23420787.
- PMID 26639528.
- PMID 26639528.
- ^ PMID 31212656.
- PMID 31689647.
- PMID 32974742.
- ^ PMID 30065845.